ADALIMUMAB IS EFFECTIVE FOR INDUCING CLINICAL REMISSION AT WEEK 4 REGARDLESS OF BASELINE CORTICOSTEROID USE: POOLED ANALYSIS OF 4 CLINICAL TRIALS

(1) Centre Hospitalier, Universitaire de Lille, Lille, France

(2) University Hospital ofGasthuisberg, Leuven, Belgium

(3) Medical University Vienna, Vienna, Austria

(4) Division of Gastroenterologyand Hepatology, Mayo Clinic, Rochester, MN, United States

(5) Department of Gastroenterology, Hospital Clinic, Barcelona, Spain

(6) Abbott GmbH & Co. KG, Ludwigshafen, Germany

(7) Abbott, Abbott Park, IL, UnitedStates



This item was part of the Inflammatory Bowel Disease I session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A187